| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5708709 | The Journal of Arthroplasty | 2017 | 5 Pages |
Abstract
ASA 81 mg is associated with significantly less GI distress and nausea compared with ASA 325 mg. GI bleeding was equally prevalent between the 2 dosing regimens, so patients need to be informed of this risk regardless of the ASA dose.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Michael J. MD, SM, Sara L. MD, Antonia F. MD, MBA, Laura A. DNP, ANP-C, William J. MD,